Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma

NCT05422027 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Selinexor
DRUG: Bortezomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Xia Zhongjun

Collaborators

[object Object]